Dashboard
Manage Tickers

YMAB Y-mAbs Therapeutics, Inc.


$ 8.60 $ 0.02 (0.23 %)    

Monday, 15-Sep-2025 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
$ 8.59
$ 0.00 x 0
$ 0.00 x 0
-- - --
$ 3.55 - $ 16.11
760,675
na
391.22M
$ 1.75
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

deal-dispatch-performance-food-group-and-claires-lead-a-week-of-big-auctions-retail-woes
Deal Dispatch: Performance Food Group And ...
08/08/2025 20:02:31

Performance Food rejects offer; Lufthansa drops Air Europa bid; NFL inks deal with ESPN; Claire's files bankruptcy amid ret...

y-mabs-therapeutics-q2-eps-007-beats-026-estimate-sales-1952m-beat-1839m-estimate
Y-mAbs Therapeutics Q2 EPS $(0.07) Beats $...
08/08/2025 10:36:12

Core News & Articles
Earnings Scheduled For August 8, 2025
08/08/2025 08:32:13

a-look-ahead-y-mabs-therapeuticss-earnings-forecast
A Look Ahead: Y-mAbs Therapeutics's Earnin...
08/07/2025 16:03:39

hc-wainwright--co-downgrades-y-mabs-therapeutics-to-neutral-lowers-price-target-to-86
HC Wainwright & Co. Downgrades Y-mAbs Ther...
08/06/2025 12:10:15

HC Wainwright & Co. analyst Robert Burns downgrades Y-mAbs Therapeutics (NASDAQ:YMAB) from Buy to Neutral and lowers the...

canaccord-genuity-downgrades-y-mabs-therapeutics-to-hold-lowers-price-target-to-86
Canaccord Genuity Downgrades Y-mAbs Therap...
08/06/2025 11:06:51

Canaccord Genuity analyst Bill Maughan downgrades Y-mAbs Therapeutics (NASDAQ:YMAB) from Buy to Hold and lowers the price ta...

jones-trading-downgrades-y-mabs-therapeutics-to-hold
Jones Trading Downgrades Y-mAbs Therapeuti...
08/05/2025 21:02:55

Jones Trading analyst Justin Walsh downgrades Y-mAbs Therapeutics (NASDAQ:YMAB) from Buy to Hold.

nasdaq-down-50-points-ism-services-pmi-declines-in-july
Nasdaq Down 50 Points; ISM Services PMI De...
08/05/2025 17:48:13

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/05/2025 17:06:56

dow-surges-over-100-points-pfizer-earnings-top-views
Dow Surges Over 100 Points; Pfizer Earning...
08/05/2025 13:59:13

trading-halt-halt-status-updated-at-84500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:45:...
08/05/2025 12:45:09

serb-pharmaceuticals-announces-they-have-entered-into-a-definitive-merger-agreement-under-which-serb-will-acquire-y-mabs-therapeutics-in-all-cash-transaction-for-412m
Serb Pharmaceuticals Announces They Have E...
08/05/2025 12:33:35

SERB Pharmaceuticals ("SERB"), a global specialty pharmaceutical company focused on medicines for rare diseases and med...

trading-halt-halted-at-82500-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 8:25:00 a.m. ET - ...
08/05/2025 12:25:04

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
08/01/2025 21:06:34

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/31/2025 21:07:05

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/23/2025 21:05:58

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
06/27/2025 12:07:16

oppenheimer-maintains-outperform-on-y-mabs-therapeutics-lowers-price-target-to-15
Oppenheimer Maintains Outperform on Y-mAbs...
05/29/2025 16:37:21

Oppenheimer analyst Jeff Jones maintains Y-mAbs Therapeutics (NASDAQ:YMAB) with a Outperform and lowers the price target fro...

reported-monday-y-mabs-highlights-ongoing-phase-1-trial-of-gd2-sada-prit-with-177lu-dota-at-anr-2025-in-washington-dc
Reported Monday, Y-mAbs Highlights Ongoing...
05/27/2025 06:24:14

The trial in progress poster titled "A phase 1 trial of pretargeted radioimmunotherapy with GD2-SADA: 177Lu-DOTA in patient...

what-7-analyst-ratings-have-to-say-about-y-mabs-therapeutics
What 7 Analyst Ratings Have To Say About Y...
05/19/2025 12:00:25

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION